Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ: DXCM )

89.07 +4.98 (+5.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
Deere Leads 5 Stocks With Hot Products Near Buy Points
Deere and Dexcom lead this weekend list of 5 stocks near buy points. 
Via Investor's Business Daily
Super Bowl Commercials 2023: The Complete List Of Super Bowl LVII Ads And The Companies Behind Them
Super Bowl LVII aired Sunday Feb. 12, 2023 and featured dozens of commercials advertising products and showcasing new movies and television shows. The commercials also featured many celebrity cameos... 
Via Benzinga
Looking Into DexCom's Return On Capital Employed
Via Benzinga
Analyst Ratings for DexCom
Via Benzinga
DexCom (DXCM) Q4 2022 Earnings Call Transcript
DXCM earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Dexcom Advances On Fourth-Quarter Beat, Reiterates Its 2023 Sales Expectations
Shares rose closer to a buy point in late action Thursday. 
Via Investor's Business Daily
2 Growth Stocks That Could Help Make You a Fortune
These companies have what it takes to deliver outsized returns over the long haul. 
Via The Motley Fool
Cramer: This Big US Bank Stock Can 'Go Much Higher In This Environment'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said A. O. 
Via Benzinga
Dexcom G7 Continuous Glucose Monitoring System Will Be Available to Medicare Beneficiaries at Launch
From Dexcom, Inc.
Via Business Wire
2 Top Healthcare Stocks to Buy for the Long Haul
The healthcare industry is booming, and this presents no shortage of opportunities to invest in promising businesses. 
Via The Motley Fool
A Preview Of DexCom's Earnings
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $49,000 Today
Via Benzinga
Procter & Gamble's Prices, China's Population, and More
Plus, Dexcom CEO Kevin Sayer shares some insight on continuous glucose monitors. 
Via The Motley Fool
Stock Market Pulls Back As Treasury Yields Jump; Google Dives On AI Flop: Weekly Review
Is this a normal, healthy pullback or the start of something more? 
Via Investor's Business Daily
Lions Gate Entertainment, DexCom, Yelp And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 100 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
The Super Bowl LVII Commercials List: From A Breaking Bad Reunion To Ozzy Osbourne, The Celebrities And 21 Stocks To Watch
A 30-second commercial during Super Bowl LVII costs around $7 million. For some companies hoping to increase their brand recognition or introduce a new product, the price is worth it. 
Via Benzinga
Dexcom Reports Fourth Quarter and Fiscal Year 2022 Financial Results
From DexCom, Inc.
Via Business Wire
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Expanding Platform to Integrate Market-Leading CGM Data
Via Investor Brand Network
2 Stock-Split Stocks to Buy Without Hesitation in 2023
These companies have rock-solid businesses that can enrich investors over the long term. 
Via The Motley Fool
Dexcom and Nick Jonas Make Super Bowl Magic to Launch New Dexcom G7 Continuous Glucose Monitoring System
From DexCom, Inc.
Via Business Wire
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond
These companies should be able to carry their momentum well beyond this year. 
Via The Motley Fool
Costco Wholesale, Micron Technology And This Healthcare Stock Insiders Are Selling
The Nasdaq jumped by around 190 points on Tuesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Is Abbott Laboratories a Good Dividend Stock to Buy Now?
At least four Wall Street banks recently raised their price targets for the healthcare giant. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
Via Benzinga
Dexcom Schedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call for February 9, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
2 No-Brainer Growth Stocks to Buy Right Now
Don't overlook these growth plays. 
Via The Motley Fool
Insulet Has Potential To Gain More Than Analysts Are Forecasting
Even as it pulled back with the broader market Tuesday, insulin pump maker Insulet found support along its 50-day line and remained in possible buy range. 
Via MarketBeat
The Top 7 “Millionaire-Maker” Long-Term Stocks for 2023
These companies have a track record of rewarding shareholders who own their stock over the long-term, providing gains of 1,000% or more. 
Via InvestorPlace
Stock Market Rally Gains Steam As Inflation Cools; Tesla Price Cuts, Big Earnings In Focus: Weekly Review
Sharp Tesla price cuts and some notable earnings were in focus. 
Via Investor's Business Daily
2 Best Stocks to Buy in January and Hold Forever
The new year is here, and with it, more opportunities to invest in wonderful companies. 
Via The Motley Fool
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.